Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Schultz

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Cells|March 11, 2023
Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis InductionAude Jehl, Ombline Conrad, Mickaël Burgy, et al.
Oral Oncology|May 14, 2022
Salvage total glossectomy and total glosso-laryngectomy: Are they worth it? A GETTEC French multicenter studyPaul Mazerolle, Carine Fuchsmann, Philippe Schultz, et al.
Surgical Oncology|March 11, 2019
Evolution and predictive factors of quality of life in patients undergoing oncologic surgery for head and neck cancer: A prospective multicentric studyAlexandre Bozec, Philippe Schultz, Jocelyn Gal, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 27, 2019
Evaluation of the information given to patients undergoing total pharyngolaryngectomy and quality of life: a prospective multicentric studyAlexandre Bozec, Philippe Schultz, Jocelyn Gal, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2016
Evaluation of the information given to patients undergoing head and neck cancer surgery using the EORTC QLQ-INFO25 questionnaire: A prospective multicentric studyAlexandre Bozec, Philippe Schultz, Jocelyn Gal, et al.
Frontiers in Immunology|November 29, 2023
A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancerJana Mourtada, Christelle Lony, Anaïs Nicol, et al.
Frontiers in Oncology|November 15, 2021
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 PatientsHélène Carinato, Mickaël Burgy, Régine Ferry, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 20, 2021
Oral tongue squamous cell carcinomas in young patients according to their smoking status: a GETTEC studySophie Deneuve, Joanne Guerlain, Agnès Dupret-Bories, et al.
Oncotarget|January 26, 2019
Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck CancerChristian Borel, Olivier Regnier-Gavier, Hélène Carinato, et al.
International Journal of Molecular Sciences|July 14, 2023
Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and TumoroidsOmbline Conrad, Mickaël Burgy, Sophie Foppolo, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cells|March 11, 2023
Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis InductionAude Jehl, Ombline Conrad, Mickaël Burgy, et al.
Oral Oncology|May 14, 2022
Salvage total glossectomy and total glosso-laryngectomy: Are they worth it? A GETTEC French multicenter studyPaul Mazerolle, Carine Fuchsmann, Philippe Schultz, et al.
Surgical Oncology|March 11, 2019
Evolution and predictive factors of quality of life in patients undergoing oncologic surgery for head and neck cancer: A prospective multicentric studyAlexandre Bozec, Philippe Schultz, Jocelyn Gal, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 27, 2019
Evaluation of the information given to patients undergoing total pharyngolaryngectomy and quality of life: a prospective multicentric studyAlexandre Bozec, Philippe Schultz, Jocelyn Gal, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2016
Evaluation of the information given to patients undergoing head and neck cancer surgery using the EORTC QLQ-INFO25 questionnaire: A prospective multicentric studyAlexandre Bozec, Philippe Schultz, Jocelyn Gal, et al.
Frontiers in Immunology|November 29, 2023
A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancerJana Mourtada, Christelle Lony, Anaïs Nicol, et al.
Frontiers in Oncology|November 15, 2021
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 PatientsHélène Carinato, Mickaël Burgy, Régine Ferry, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 20, 2021
Oral tongue squamous cell carcinomas in young patients according to their smoking status: a GETTEC studySophie Deneuve, Joanne Guerlain, Agnès Dupret-Bories, et al.
Oncotarget|January 26, 2019
Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck CancerChristian Borel, Olivier Regnier-Gavier, Hélène Carinato, et al.
International Journal of Molecular Sciences|July 14, 2023
Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and TumoroidsOmbline Conrad, Mickaël Burgy, Sophie Foppolo, et al.
Pageof 5